Acutaas Chemicals profit and loss

Latest FY26

Revenue: ₹1,339cr+33.0% on FY25
EBITDA: ₹480cr+107.0% on FY25
Net profit: ₹356cr+122.2% on FY25
EPS: ₹43.51+119.6% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	1,593	1,339	1,007	717	617	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	22.7	41.6	16.9	7.5	4.3
	1,615	1,381	1,024	725	621
	682	595	570	440	346
	−44.1	−29.0	−17.6	−28.5	−15.0
	145	118	83.7	63.1	48.8
	4.2	3.3	6.2	5.9	2.4
	42.0	36.0	26.6	16.1	12.3
	187	175	139	114	114
	1,015	898	808	611	509
	623	480	232	128	123
	581	444	205	112	110
Profit
	600	483	216	114	112
	0.0	0.0	0.0	−32.1	0.0
	600	483	216	81.9	112
	152	117	49.2	29.0	26.4
	9.6	9.2	6.6	4.2	2.5
	161	126	55.7	33.2	28.9
	439	356	160	48.7	83.3
	439	356	160	48.7	83.3
	21.9	−3.2	−0.1	−7.2	3.1
	461	353	160	41.5	86.4
	439	356	159	42.8	—
	−0.5	0.1	1.7	5.9	—
Per share
	₹53.64	₹43.51	₹19.81	₹11.67	₹22.86
	₹53.42	₹43.37	₹19.81	₹11.66	₹22.86
Other comprehensive income — detail
	21.9	−3.2	−0.1	—	—
	−0.1	−0.4	−0.2	−0.0	3.1
	−0.1	−0.1	−0.0	—	—
	—	—	—	0.0	0.1
	—	−3.0	—	−7.2	0.0
	455	353	159	35.5	86.4
	5.8	0.1	1.7	6.0	0.0
Per share — as-filed variants
	₹53.64	₹43.51	₹19.81	₹11.67	₹22.86
	₹53.42	₹43.37	₹19.81	₹11.66	₹22.86
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	955	773	455	306	286
	59.9%	57.7%	45.2%	42.6%	46.3%
Adjusted (ex-exceptional items) — derived
	600	483	216	114	112
	0.0	0.0	0.0	−32.1	0.0
	439	356	160	67.8	83.3
	₹53.64	₹43.51	₹19.81	₹16.24	₹22.86

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ACUTAAS₹3,976.70

Acutaas Chemicals Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersANURAS AETHER BLUEJET CAPLIPOINT CONCORDBIO EMCURE JBCHEPHARM ERISMcap ₹32,558 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Revenue from Operations	616.7	717.5	1,006.9	1,339.4	1,592.5
Other Income	4.3	7.5	16.9	41.6	22.7
Total Income	621.1	725.0	1,023.8	1,381.0	1,615.2
Expenses
+ Cost of Materials Consumed	345.9	440.2	569.8	595.0	681.9
+ Changes in Inventories	-15.0	-28.5	-17.6	-29.0	-44.1
+ Employee Benefit Expense	48.8	63.1	83.7	117.6	144.8
+ Finance Costs	2.4	5.9	6.2	3.3	4.2
+ Depreciation & Amortisation	12.3	16.1	26.6	36.0	42.0
+ Other Expenses	114.4	114.2	139.0	175.4	186.7
Total Expenses	508.9	611.0	807.6	898.2	1,015.5
EBITDA	122.6	128.5	232.1	480.4	623.2
EBIT	110.3	112.4	205.5	444.4	581.2
Profit
PBT before Exceptional Items	112.2	114.0	216.2	482.7	599.7
+ Exceptional Items	0.0	-32.1	0.0	0.0	0.0
Pretax Income	112.2	81.9	216.2	482.7	599.7
+ Current Tax	26.4	29.0	49.2	117.2	151.5
+ Deferred Tax	2.5	4.2	6.6	9.2	9.6
Tax Expense	28.9	33.2	55.7	126.4	161.1
Net Income	83.3	48.7	160.4	356.4	438.6
+ Net Income — Continuing Ops	83.3	48.7	160.4	356.4	438.6
+ Other Comprehensive Income	3.1	-7.2	-0.1	-3.2	21.9
Total Comprehensive Income	86.4	41.5	160.3	353.1	460.5
Net Income to Common	—	42.8	158.7	356.3	439.2
Minority Interest	—	5.9	1.7	0.1	-0.5
Per Share
Basic EPS	22.86	11.67	19.81	43.51	53.64
Diluted EPS	22.86	11.66	19.81	43.37	53.42
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.1	-3.2	21.9
+ Items NOT to be Reclassified to P&L	3.1	-0.0	-0.2	-0.4	-0.1
+ Tax on Items NOT to be Reclassified	—	—	-0.0	-0.1	-0.1
+ Tax on Items NOT to be Reclassified — alt tag	0.1	0.0	—	—	—
+ Items to be Reclassified to P&L	0.0	-7.2	—	-3.0	—
Comprehensive Income — Owners of Parent	86.4	35.5	158.6	353.0	454.7
Comprehensive Income — Non-controlling Interests	0.0	6.0	1.7	0.1	5.8
Per Share — as-filed variants
Basic EPS — Continuing Operations	22.86	11.67	19.81	43.51	53.64
Diluted EPS — Continuing Operations	22.86	11.66	19.81	43.37	53.42
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	285.8	305.8	454.7	773.4	954.7
Gross Margin %	46.35	42.62	45.16	57.74	59.95
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	112.2	114.0	216.2	482.7	599.7
− Exceptional Items (reconciliation)	0.0	-32.1	0.0	0.0	0.0
Net Income Adj (tax-effected)	83.3	67.8	160.4	356.4	438.6
EPS Adj	22.86	16.24	19.81	43.51	53.64
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	5.00	5.00	5.00
Paid Up Equity Capital	36.4	36.9	40.9	40.9	40.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.